Spero Therapeutics
SPRO
SPRO
94 hedge funds and large institutions have $273M invested in Spero Therapeutics in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
26% less capital invested
Capital invested by funds: $370M → $273M (-$97M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
44% less call options, than puts
Call options by funds: $889K | Put options by funds: $1.58M
Holders
94
Holding in Top 10
2
Calls
$889K
Puts
$1.58M
Top Buyers
| 1 | +$15M | |
| 2 | +$3.15M | |
| 3 | +$2.49M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.36M |
| 5 |
Citigroup
New York
|
+$1.19M |
Top Sellers
| 1 | -$3.96M | |
| 2 | -$1.59M | |
| 3 | -$1.55M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$1.52M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$1.52M |